TSPO and early-onset autosomal dominant Alzheimer disease: Increased TSPO expression is commonly used as a marker of neuroinflammation in traumatic brain injury and neurodegenerative disorders including Alzheimer’s disease and Parkinson’s disease [38], but is currently being investigated as a measure of systemic inflammation for other applications including cancer [48–50].